Literature DB >> 16627939

Structure of T4moC, the Rieske-type ferredoxin component of toluene 4-monooxygenase.

Luke A Moe1, Craig A Bingman, Gary E Wesenberg, George N Phillips, Brian G Fox.   

Abstract

The structure of the Rieske-type ferredoxin (T4moC) from toluene 4-monooxygenase was determined by X-ray crystallography in the [2Fe-2S](2+) state at a resolution of 1.48 A using single-wavelength anomalous dispersion phasing with the [2Fe-2S] center. The structure consists of ten beta-strands arranged into the three antiparallel beta-sheet topology observed in all Rieske proteins. Trp69 of T4moC is adjacent to the [2Fe-2S] centre, which displaces a loop containing the conserved Pro81 by approximately 8 A away from the [2Fe-2S] cluster compared with the Pro loop in the closest structural and functional homolog, the Rieske-type ferredoxin BphF from biphenyl dioxygenase. In addition, T4moC contains five hydrogen bonds to the [2Fe-2S] cluster compared with three hydrogen bonds in BphF. Moreover, the electrostatic surface of T4moC is distinct from that of BphF. These structural differences are identified as possible contributors to the evolutionary specialization of soluble Rieske-type ferredoxins between the diiron monooxygenases and cis-dihydrodiol-forming dioxygenases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627939     DOI: 10.1107/S0907444906006056

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  10 in total

1.  Soluble expression and purification of the oxidoreductase component of toluene 4-monooxygenase.

Authors:  Lucas J Bailey; Nathaniel L Elsen; Brad S Pierce; Brian G Fox
Journal:  Protein Expr Purif       Date:  2007-09-19       Impact factor: 1.650

2.  Performance of ZDOCK in CAPRI rounds 20-26.

Authors:  Thom Vreven; Brian G Pierce; Howook Hwang; Zhiping Weng
Journal:  Proteins       Date:  2013-12

3.  The iron-sulfur core in Rieske proteins is not symmetric.

Authors:  Md Ehesan Ali; Nisanth N Nair; Marius Retegan; Frank Neese; Volker Staemmler; Dominik Marx
Journal:  J Biol Inorg Chem       Date:  2014-08-24       Impact factor: 3.358

4.  The reduction rates of DEPC-modified mutant Thermus thermophilus Rieske proteins differ when there is a negative charge proximal to the cluster.

Authors:  Nicholas E Karagas; Christie N Jones; Deborah J Osborn; Anika L Dzierlenga; Paul Oyala; Mary E Konkle; Emily M Whitney; R David Britt; Laura M Hunsicker-Wang
Journal:  J Biol Inorg Chem       Date:  2014-06-11       Impact factor: 3.358

5.  Two-dimensional pulsed electron spin resonance characterization of 15N-labeled archaeal Rieske-type ferredoxin.

Authors:  Toshio Iwasaki; Rimma I Samoilova; Asako Kounosu; Sergei A Dikanov
Journal:  FEBS Lett       Date:  2009-10-03       Impact factor: 4.124

6.  Inclusion of the orientational entropic effect and low-resolution experimental information for protein-protein docking in Critical Assessment of PRedicted Interactions (CAPRI).

Authors:  Sheng-You Huang; Chengfei Yan; Sam Z Grinter; Shan Chang; Lin Jiang; Xiaoqin Zou
Journal:  Proteins       Date:  2013-11-14

7.  Component interactions and electron transfer in toluene/o-xylene monooxygenase.

Authors:  Alexandria Deliz Liang; Stephen J Lippard
Journal:  Biochemistry       Date:  2014-11-17       Impact factor: 3.162

8.  Structures of the multicomponent Rieske non-heme iron toluene 2,3-dioxygenase enzyme system.

Authors:  Rosmarie Friemann; Kyoung Lee; Eric N Brown; David T Gibson; Hans Eklund; S Ramaswamy
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-12-18

9.  X-ray structure of a soluble Rieske-type ferredoxin from Mus musculus.

Authors:  Elena J Levin; Nathaniel L Elsen; Kory D Seder; Jason G McCoy; Brian G Fox; George N Phillips
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-08-13

10.  Structural basis for biomolecular recognition in overlapping binding sites in a diiron enzyme system.

Authors:  Justin F Acheson; Lucas J Bailey; Nathaniel L Elsen; Brian G Fox
Journal:  Nat Commun       Date:  2014-09-24       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.